Home
Charts
Search
Watchlist
Products
All IPOs
₹189 - 189
Credent Connect N Care Ltd
HealthcareIPOSME
₹189 - 189
Our company is a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions across India. We provide comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises through end-to-end solutions.
Lot600Min Invest₹2,26,800Face Value₹10Issue Size₹94 CrFresh Issue₹94 CrListing Price₹359CMP₹318
Timeline
13 Aug
Bidding opens
17 Aug
Bidding closes
18 Aug
Allotment
19 Aug
Refund & demat credit
20 Aug
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹94 Cr0.50 Cr shares
Fresh Issue₹94 Cr
Face Value₹10
Lot Size600 shares
ReservationQIB 49.87% · NII 15.01% · RETAIL 35.12%
Application Sizes
Retail₹2,26,8001-1 lots
sNII₹2,26,800from 2 lots
bNII₹10,20,600from 9 lots
Managers & Registrar
Lead ManagerHEM Securities Limited
RegistrarKFin Technologies Ltd
Ownership & Proceeds
Shareholding
CategoryPre IPOPost IPOPromoter Group87.64%63.76%Public12.36%36.24%
Objects of the Issue
- Investment in the company wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement
- Investment in the company wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery
- To meet Working Capital Requirements
- Repayment and/or repayment, in full or part, of borrowing availed by its Company
- General corporate purposes
Anchor Book
Bid Date12-Aug-2026
Financials
Profit & Loss
| Financial Year | FY26 |
|---|---|
| RevenueCr | 214 |
| Operating ProfitCr | 29 |
| OPM% | 13.4 |
| PBTCr | 25 |
| PATCr | 18 |
| EPS | 14 |
Balance Sheet
| Financial Year | FY26 |
|---|---|
| Equity CapitalCr | 13 |
| ReservesCr | 31 |
| BorrowingsCr | 22 |
| Total AssetsCr | 82 |
Cash Flow
| Financial Year | FY26 |
|---|---|
| Operating Cash FlowCr | -7 |
| Investing Cash FlowCr | -11 |
| Financing Cash FlowCr | 19 |
| Net Cash FlowCr | 1 |
Strengths & Risks
Strengths · as stated in the DRHP
- Comprehensive Healthcare Ecosystem and Logistics Platform.
- Well established relationships with clients .
- Leveraging the experience of our Promoters and Directors .
- Widespread reach in domestic markets.
Strategies · as stated in the DRHP
- Continue to invest in technological capabilities.
- Deepen Client Engagement and Expand Services.
- Attract, develop and retain skilled employees.
- Enhancing Operating Effectiveness and Efficiency.
Risks · as stated in the DRHP
- The company derives a significant portion of its revenue from operations from the company's top 10 customers with which the company does not has any firm commitments. The loss of any one or more of its major customers would have a material adverse effect on the company's business, cash flows, results of operations and financial condition.
- The company's business is dependent on diagnostic and healthcare companies, and any reduction in their testing volumes, outsourcing requirements, or adverse sector developments could materially and adversely affect its business, financial condition, and results of operations.
- The company is exposed to risks relating to loss, damage, contamination or delay in transportation of diagnostic samples, which could result in client claims, financial liabilities and reputational harm.
- The company's business depends on service-level contracts with clients that are subject to renewal, renegotiation and termination, and its inability to maintain or renew such contracts on favourable terms could materially and adversely affect the company's business.
- The company's business is working capital intensive and trade receivables constitute a significant portion of its current assets. Any delay or failures in realisation of trade receivables could adversely affect its cash flows, liquidity and financial condition.
- The company's business is highly dependent on the availability and performance of a large, skilled and geographically dispersed workforce, and its inability to effectively manage, train and retain such personnel could adversely affect its operations.